Skip to main content

Table 2 Sum of total and CBD-specific violations by month, venue, and violation type

From: Unsubstantiated health claims for COVID-19 infections are led by cannabidiol: return of snake oil medicine

Category

CBD-related violations

Total violations

n (%)

n (%)

Month of issuance

 March, 2020

1 (6.7)

12 (9.2)

 April, 2020

4 (26.7)

28 (21.5)

 May, 2020

4 (26.7)

26 (20.0)

 June, 2020

1 (6.7)

8 (6.2)

 July, 2020

0 (0.0)

11 (8.5)

 August, 2020

1 (6.7)

6 (4.6)

 September, 2020

0 (0.0)

2 (1.5)

 October, 2020

1 (6.7)

4 (3.0)

 November, 2020

0 (0.0)

2 (1.5)

 December, 2020

1 (6.7)

7 (5.4)

 January, 2021

0 (0.0)

4 (3.1)

 February, 2021

0 (0.0)

1 (0.8)

 March, 2021

1 (6.7)

3 (2.3)

 April, 2021

0 (0.0)

4 (3.1)

 May, 2021

0 (0.0)

4 (3.1)

 June, 2021

0 (0.0)

1 (0.8)

 July, 2021

1 (6.7)

4 (3.1)

 August, 2021

0 (0.0)

3 (2.3)

Promotional venue

 Website

15 (100.0)

128 (98.5)

 Facebook

8 (53.3)

49 (37.7)

 YouTube

0 (0.0)

6 (4.6)

 Instagram

4 (26.7)

15 (11.5)

 Twitter

5 (33.3)

20 (15.4)

 LinkedIn

1 (6.7)

3 (2.3)

 Email

0 (0.0)

1 (0.8)

Type of violation

 Unapproved product

15 (100.0)

130 (100.0)

 Misbranding

15 (100.0)

127 (97.7)

 Unsubstantiated claims

14 (93.3)

115 (88.5)

Mechanism of action

 Anti-viral

5 (33.3)

-

 Pro-inflammatory

1 (6.7)

-

 Anti-inflammatory

7 (46.7)

-

 Immune-booster

6 (40.0)

-

 Immune-suppressor

2 (13.3)

-

 Other

2 (13.3)

-